(R)-5-(4-methyl-5-(1-(2-m-tolyl-2H-tetrazol-5-yl)ethoxy)-4H-1,2,4-triazol-3-yl)pyridazin-3(2H)-one

ID: ALA3759977

Chembl Id: CHEMBL3759977

PubChem CID: 24853384

Max Phase: Preclinical

Molecular Formula: C17H17N9O2

Molecular Weight: 379.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(-n2nnc([C@@H](C)Oc3nnc(-c4cn[nH]c(=O)c4)n3C)n2)c1

Standard InChI:  InChI=1S/C17H17N9O2/c1-10-5-4-6-13(7-10)26-23-15(20-24-26)11(2)28-17-22-21-16(25(17)3)12-8-14(27)19-18-9-12/h4-9,11H,1-3H3,(H,19,27)/t11-/m1/s1

Standard InChI Key:  UBBUIIAEFUPFIG-LLVKDONJSA-N

Associated Targets(Human)

GRM5 Tchem Metabotropic glutamate receptor 5 (5733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.38Molecular Weight (Monoisotopic): 379.1505AlogP: 0.99#Rotatable Bonds: 5
Polar Surface Area: 129.29Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.41CX Basic pKa: 0.84CX LogP: 2.00CX LogD: 2.00
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -1.66

References

1. Topiol S, Sabio M..  (2016)  7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.,  26  (2): [PMID:26706173] [10.1016/j.bmcl.2015.11.087]
2.  (2008)  MgluR5 modulators,